Chloe Glaros, Caroline K Tietbohl, Kristen A Torres, Rafaela Avallone Mantelli, D Clark Files, Matthew F Mart, Michael A Matthay, Karen E A Burns, Daniel D Matlock, Matthew Wynia, Marc Moss
{"title":"重症监护研究中代理知情同意过程的表现:一项多模式研究,研究人员、协调员、代理和患者。","authors":"Chloe Glaros, Caroline K Tietbohl, Kristen A Torres, Rafaela Avallone Mantelli, D Clark Files, Matthew F Mart, Michael A Matthay, Karen E A Burns, Daniel D Matlock, Matthew Wynia, Marc Moss","doi":"10.1016/j.chest.2025.05.038","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Although surrogates are often required to participate in the informed consent process for critical care research, how to best engage surrogates in this process remains unclear.</p><p><strong>Research question: </strong>What are the best practices for conducting the surrogate informed consent processes for critical care research?</p><p><strong>Study design and methods: </strong>This mixed-methods study was performed across academic medical centers located in the United States. It included quantitative surveys with open-ended questions, focus groups, and semi-structured interviews with principal investigators (PIs), research coordinators (RCs), and surrogate decision makers (SDMs) who were approached about a critical care research clinical trial and, when possible, the patient who had been critically ill. Both quantitative and qualitative thematic methods were used in the analysis.</p><p><strong>Results: </strong>In total, 230 individuals (105 RC, 90 PI, 27 surrogates, and 8 patients) completed surveys, and 61 participated in focus groups/interviews. In both surveys and focus groups/interviews, participants across all groups believed that RCs (as opposed to PIs) should conduct the consent process, as RCs are not considered to be authority figures and have fewer perceived conflicts of interest. Surrogates appreciated it when research staff waited until there was an optimal time to initiate contact and were given physical space and a defined period to consider their decision. Compared with PI/RCs, SDMs and/or patients (in surveys) expressed appreciation for the research team's updates on the patient's condition and were more enthusiastic that a perceived advantage of research was that it could help with adherence to clinical protocols (P < .0001, P = .0016). Compared with PI/RCs, SDMs thought the written consent was more important and were less concerned with its length (P = .001, P < .0001). All participants felt that telephone/electronic consents were less effective than in-person consent, although these modalities could facilitate the inclusion of SDMs who lived far away.</p><p><strong>Interpretation: </strong>This study identified several strategies that could enhance the surrogate informed consent process for critical care research.</p>","PeriodicalId":9782,"journal":{"name":"Chest","volume":" ","pages":""},"PeriodicalIF":8.6000,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Performance of the Surrogate Informed Consent Process for Critical Care Research: A Multi-Modal Study of Investigators, Coordinators, Surrogates, and Patients.\",\"authors\":\"Chloe Glaros, Caroline K Tietbohl, Kristen A Torres, Rafaela Avallone Mantelli, D Clark Files, Matthew F Mart, Michael A Matthay, Karen E A Burns, Daniel D Matlock, Matthew Wynia, Marc Moss\",\"doi\":\"10.1016/j.chest.2025.05.038\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Although surrogates are often required to participate in the informed consent process for critical care research, how to best engage surrogates in this process remains unclear.</p><p><strong>Research question: </strong>What are the best practices for conducting the surrogate informed consent processes for critical care research?</p><p><strong>Study design and methods: </strong>This mixed-methods study was performed across academic medical centers located in the United States. It included quantitative surveys with open-ended questions, focus groups, and semi-structured interviews with principal investigators (PIs), research coordinators (RCs), and surrogate decision makers (SDMs) who were approached about a critical care research clinical trial and, when possible, the patient who had been critically ill. Both quantitative and qualitative thematic methods were used in the analysis.</p><p><strong>Results: </strong>In total, 230 individuals (105 RC, 90 PI, 27 surrogates, and 8 patients) completed surveys, and 61 participated in focus groups/interviews. In both surveys and focus groups/interviews, participants across all groups believed that RCs (as opposed to PIs) should conduct the consent process, as RCs are not considered to be authority figures and have fewer perceived conflicts of interest. Surrogates appreciated it when research staff waited until there was an optimal time to initiate contact and were given physical space and a defined period to consider their decision. Compared with PI/RCs, SDMs and/or patients (in surveys) expressed appreciation for the research team's updates on the patient's condition and were more enthusiastic that a perceived advantage of research was that it could help with adherence to clinical protocols (P < .0001, P = .0016). Compared with PI/RCs, SDMs thought the written consent was more important and were less concerned with its length (P = .001, P < .0001). All participants felt that telephone/electronic consents were less effective than in-person consent, although these modalities could facilitate the inclusion of SDMs who lived far away.</p><p><strong>Interpretation: </strong>This study identified several strategies that could enhance the surrogate informed consent process for critical care research.</p>\",\"PeriodicalId\":9782,\"journal\":{\"name\":\"Chest\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":8.6000,\"publicationDate\":\"2025-06-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Chest\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.chest.2025.05.038\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CRITICAL CARE MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chest","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.chest.2025.05.038","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
The Performance of the Surrogate Informed Consent Process for Critical Care Research: A Multi-Modal Study of Investigators, Coordinators, Surrogates, and Patients.
Background: Although surrogates are often required to participate in the informed consent process for critical care research, how to best engage surrogates in this process remains unclear.
Research question: What are the best practices for conducting the surrogate informed consent processes for critical care research?
Study design and methods: This mixed-methods study was performed across academic medical centers located in the United States. It included quantitative surveys with open-ended questions, focus groups, and semi-structured interviews with principal investigators (PIs), research coordinators (RCs), and surrogate decision makers (SDMs) who were approached about a critical care research clinical trial and, when possible, the patient who had been critically ill. Both quantitative and qualitative thematic methods were used in the analysis.
Results: In total, 230 individuals (105 RC, 90 PI, 27 surrogates, and 8 patients) completed surveys, and 61 participated in focus groups/interviews. In both surveys and focus groups/interviews, participants across all groups believed that RCs (as opposed to PIs) should conduct the consent process, as RCs are not considered to be authority figures and have fewer perceived conflicts of interest. Surrogates appreciated it when research staff waited until there was an optimal time to initiate contact and were given physical space and a defined period to consider their decision. Compared with PI/RCs, SDMs and/or patients (in surveys) expressed appreciation for the research team's updates on the patient's condition and were more enthusiastic that a perceived advantage of research was that it could help with adherence to clinical protocols (P < .0001, P = .0016). Compared with PI/RCs, SDMs thought the written consent was more important and were less concerned with its length (P = .001, P < .0001). All participants felt that telephone/electronic consents were less effective than in-person consent, although these modalities could facilitate the inclusion of SDMs who lived far away.
Interpretation: This study identified several strategies that could enhance the surrogate informed consent process for critical care research.
期刊介绍:
At CHEST, our mission is to revolutionize patient care through the collaboration of multidisciplinary clinicians in the fields of pulmonary, critical care, and sleep medicine. We achieve this by publishing cutting-edge clinical research that addresses current challenges and brings forth future advancements. To enhance understanding in a rapidly evolving field, CHEST also features review articles, commentaries, and facilitates discussions on emerging controversies. We place great emphasis on scientific rigor, employing a rigorous peer review process, and ensuring all accepted content is published online within two weeks.